COVID-19 Impact on Global Personalized Medicine Market Size, Status and Forecast 2020-2026
Individualized medication, medication 'vary from person to person' , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Personalized Medicine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Personalized Medicine industry.
Based on our recent survey, we have several different scenarios about the Personalized Medicine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Personalized Medicine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Medicine market in terms of revenue.
Players, stakeholders, and other participants in the global Personalized Medicine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Personalized Medicine market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Personalized Medicine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Medicine market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Personalized Medicine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Personalized Medicine industry.
Based on our recent survey, we have several different scenarios about the Personalized Medicine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Personalized Medicine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Medicine market in terms of revenue.
Players, stakeholders, and other participants in the global Personalized Medicine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Personalized Medicine market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Personalized Medicine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Medicine market.
The following players are covered in this report:
- Abbott Laboratories
- Agilent Technologies
- Amgen
- Astellas Pharma
- Astrazeneca
- Bayer AG
- Celgene Corporation
- Glaxosmithkline Plc
- Illumina
- Johnson & Johnson
- Laboratory Corporation
- Merck
- Novartis AG
- Roche Holding AG
- Siemens AG
- Takeda Pharmaceutical Company Limited
- Personalized Medicine Diagnostics
- Personalized Medical Care
- Personalized Medicine Therapeutics
- Personalized Nutrition and Wellness
- Oncology
- Central Nervous System (CNS)
- Immunology
- Respiratory
- Other Applications
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Personalized Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Personalized Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Personalized Medicine Diagnostics
1.4.3 Personalized Medical Care
1.4.4 Personalized Medicine Therapeutics
1.4.5 Personalized Nutrition and Wellness
1.5 Market by Application
1.5.1 Global Personalized Medicine Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Central Nervous System (CNS)
1.5.4 Immunology
1.5.5 Respiratory
1.5.6 Other Applications
1.6 Coronavirus Disease 2019 (Covid-19): Personalized Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Personalized Medicine Industry
1.6.1.1 Personalized Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Personalized Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Personalized Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Personalized Medicine Market Perspective (2015-2026)
2.2 Personalized Medicine Growth Trends by Regions
2.2.1 Personalized Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Personalized Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Personalized Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Personalized Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Personalized Medicine Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Personalized Medicine Players by Market Size
3.1.1 Global Top Personalized Medicine Players by Revenue (2015-2020)
3.1.2 Global Personalized Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Personalized Medicine Market Concentration Ratio
3.2.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2019
3.3 Personalized Medicine Key Players Head office and Area Served
3.4 Key Players Personalized Medicine Product Solution and Service
3.5 Date of Enter into Personalized Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Personalized Medicine Historic Market Size by Type (2015-2020)
4.2 Global Personalized Medicine Forecasted Market Size by Type (2021-2026)
5 PERSONALIZED MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Personalized Medicine Market Size by Application (2015-2020)
5.2 Global Personalized Medicine Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Personalized Medicine Market Size (2015-2020)
6.2 Personalized Medicine Key Players in North America (2019-2020)
6.3 North America Personalized Medicine Market Size by Type (2015-2020)
6.4 North America Personalized Medicine Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Personalized Medicine Market Size (2015-2020)
7.2 Personalized Medicine Key Players in Europe (2019-2020)
7.3 Europe Personalized Medicine Market Size by Type (2015-2020)
7.4 Europe Personalized Medicine Market Size by Application (2015-2020)
8 CHINA
8.1 China Personalized Medicine Market Size (2015-2020)
8.2 Personalized Medicine Key Players in China (2019-2020)
8.3 China Personalized Medicine Market Size by Type (2015-2020)
8.4 China Personalized Medicine Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Personalized Medicine Market Size (2015-2020)
9.2 Personalized Medicine Key Players in Japan (2019-2020)
9.3 Japan Personalized Medicine Market Size by Type (2015-2020)
9.4 Japan Personalized Medicine Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Personalized Medicine Market Size (2015-2020)
10.2 Personalized Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Personalized Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Personalized Medicine Market Size by Application (2015-2020)
11 INDIA
11.1 India Personalized Medicine Market Size (2015-2020)
11.2 Personalized Medicine Key Players in India (2019-2020)
11.3 India Personalized Medicine Market Size by Type (2015-2020)
11.4 India Personalized Medicine Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Personalized Medicine Market Size (2015-2020)
12.2 Personalized Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Personalized Medicine Market Size by Type (2015-2020)
12.4 Central & South America Personalized Medicine Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Personalized Medicine Introduction
13.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Agilent Technologies
13.2.1 Agilent Technologies Company Details
13.2.2 Agilent Technologies Business Overview and Its Total Revenue
13.2.3 Agilent Technologies Personalized Medicine Introduction
13.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2015-2020)
13.2.5 Agilent Technologies Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview and Its Total Revenue
13.3.3 Amgen Personalized Medicine Introduction
13.3.4 Amgen Revenue in Personalized Medicine Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Details
13.4.2 Astellas Pharma Business Overview and Its Total Revenue
13.4.3 Astellas Pharma Personalized Medicine Introduction
13.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2015-2020)
13.4.5 Astellas Pharma Recent Development
13.5 Astrazeneca
13.5.1 Astrazeneca Company Details
13.5.2 Astrazeneca Business Overview and Its Total Revenue
13.5.3 Astrazeneca Personalized Medicine Introduction
13.5.4 Astrazeneca Revenue in Personalized Medicine Business (2015-2020)
13.5.5 Astrazeneca Recent Development
13.6 Bayer AG
13.6.1 Bayer AG Company Details
13.6.2 Bayer AG Business Overview and Its Total Revenue
13.6.3 Bayer AG Personalized Medicine Introduction
13.6.4 Bayer AG Revenue in Personalized Medicine Business (2015-2020)
13.6.5 Bayer AG Recent Development
13.7 Celgene Corporation
13.7.1 Celgene Corporation Company Details
13.7.2 Celgene Corporation Business Overview and Its Total Revenue
13.7.3 Celgene Corporation Personalized Medicine Introduction
13.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2015-2020)
13.7.5 Celgene Corporation Recent Development
13.8 Glaxosmithkline Plc
13.8.1 Glaxosmithkline Plc Company Details
13.8.2 Glaxosmithkline Plc Business Overview and Its Total Revenue
13.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
13.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2015-2020)
13.8.5 Glaxosmithkline Plc Recent Development
13.9 Illumina
13.9.1 Illumina Company Details
13.9.2 Illumina Business Overview and Its Total Revenue
13.9.3 Illumina Personalized Medicine Introduction
13.9.4 Illumina Revenue in Personalized Medicine Business (2015-2020)
13.9.5 Illumina Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
13.10.3 Johnson & Johnson Personalized Medicine Introduction
13.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Laboratory Corporation
10.11.1 Laboratory Corporation Company Details
10.11.2 Laboratory Corporation Business Overview and Its Total Revenue
10.11.3 Laboratory Corporation Personalized Medicine Introduction
10.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2015-2020)
10.11.5 Laboratory Corporation Recent Development
13.12 Merck
10.12.1 Merck Company Details
10.12.2 Merck Business Overview and Its Total Revenue
10.12.3 Merck Personalized Medicine Introduction
10.12.4 Merck Revenue in Personalized Medicine Business (2015-2020)
10.12.5 Merck Recent Development
13.13 Novartis AG
10.13.1 Novartis AG Company Details
10.13.2 Novartis AG Business Overview and Its Total Revenue
10.13.3 Novartis AG Personalized Medicine Introduction
10.13.4 Novartis AG Revenue in Personalized Medicine Business (2015-2020)
10.13.5 Novartis AG Recent Development
13.14 Roche Holding AG
10.14.1 Roche Holding AG Company Details
10.14.2 Roche Holding AG Business Overview and Its Total Revenue
10.14.3 Roche Holding AG Personalized Medicine Introduction
10.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2015-2020)
10.14.5 Roche Holding AG Recent Development
13.15 Siemens AG
10.15.1 Siemens AG Company Details
10.15.2 Siemens AG Business Overview and Its Total Revenue
10.15.3 Siemens AG Personalized Medicine Introduction
10.15.4 Siemens AG Revenue in Personalized Medicine Business (2015-2020)
10.15.5 Siemens AG Recent Development
13.16 Takeda Pharmaceutical Company Limited
10.16.1 Takeda Pharmaceutical Company Limited Company Details
10.16.2 Takeda Pharmaceutical Company Limited Business Overview and Its Total Revenue
10.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
10.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2015-2020)
10.16.5 Takeda Pharmaceutical Company Limited Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Personalized Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Personalized Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Personalized Medicine Diagnostics
1.4.3 Personalized Medical Care
1.4.4 Personalized Medicine Therapeutics
1.4.5 Personalized Nutrition and Wellness
1.5 Market by Application
1.5.1 Global Personalized Medicine Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Central Nervous System (CNS)
1.5.4 Immunology
1.5.5 Respiratory
1.5.6 Other Applications
1.6 Coronavirus Disease 2019 (Covid-19): Personalized Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Personalized Medicine Industry
1.6.1.1 Personalized Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Personalized Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Personalized Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Personalized Medicine Market Perspective (2015-2026)
2.2 Personalized Medicine Growth Trends by Regions
2.2.1 Personalized Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Personalized Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Personalized Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Personalized Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Personalized Medicine Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Personalized Medicine Players by Market Size
3.1.1 Global Top Personalized Medicine Players by Revenue (2015-2020)
3.1.2 Global Personalized Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Personalized Medicine Market Concentration Ratio
3.2.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2019
3.3 Personalized Medicine Key Players Head office and Area Served
3.4 Key Players Personalized Medicine Product Solution and Service
3.5 Date of Enter into Personalized Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Personalized Medicine Historic Market Size by Type (2015-2020)
4.2 Global Personalized Medicine Forecasted Market Size by Type (2021-2026)
5 PERSONALIZED MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Personalized Medicine Market Size by Application (2015-2020)
5.2 Global Personalized Medicine Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Personalized Medicine Market Size (2015-2020)
6.2 Personalized Medicine Key Players in North America (2019-2020)
6.3 North America Personalized Medicine Market Size by Type (2015-2020)
6.4 North America Personalized Medicine Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Personalized Medicine Market Size (2015-2020)
7.2 Personalized Medicine Key Players in Europe (2019-2020)
7.3 Europe Personalized Medicine Market Size by Type (2015-2020)
7.4 Europe Personalized Medicine Market Size by Application (2015-2020)
8 CHINA
8.1 China Personalized Medicine Market Size (2015-2020)
8.2 Personalized Medicine Key Players in China (2019-2020)
8.3 China Personalized Medicine Market Size by Type (2015-2020)
8.4 China Personalized Medicine Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Personalized Medicine Market Size (2015-2020)
9.2 Personalized Medicine Key Players in Japan (2019-2020)
9.3 Japan Personalized Medicine Market Size by Type (2015-2020)
9.4 Japan Personalized Medicine Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Personalized Medicine Market Size (2015-2020)
10.2 Personalized Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Personalized Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Personalized Medicine Market Size by Application (2015-2020)
11 INDIA
11.1 India Personalized Medicine Market Size (2015-2020)
11.2 Personalized Medicine Key Players in India (2019-2020)
11.3 India Personalized Medicine Market Size by Type (2015-2020)
11.4 India Personalized Medicine Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Personalized Medicine Market Size (2015-2020)
12.2 Personalized Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Personalized Medicine Market Size by Type (2015-2020)
12.4 Central & South America Personalized Medicine Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Personalized Medicine Introduction
13.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Agilent Technologies
13.2.1 Agilent Technologies Company Details
13.2.2 Agilent Technologies Business Overview and Its Total Revenue
13.2.3 Agilent Technologies Personalized Medicine Introduction
13.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2015-2020)
13.2.5 Agilent Technologies Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview and Its Total Revenue
13.3.3 Amgen Personalized Medicine Introduction
13.3.4 Amgen Revenue in Personalized Medicine Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Details
13.4.2 Astellas Pharma Business Overview and Its Total Revenue
13.4.3 Astellas Pharma Personalized Medicine Introduction
13.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2015-2020)
13.4.5 Astellas Pharma Recent Development
13.5 Astrazeneca
13.5.1 Astrazeneca Company Details
13.5.2 Astrazeneca Business Overview and Its Total Revenue
13.5.3 Astrazeneca Personalized Medicine Introduction
13.5.4 Astrazeneca Revenue in Personalized Medicine Business (2015-2020)
13.5.5 Astrazeneca Recent Development
13.6 Bayer AG
13.6.1 Bayer AG Company Details
13.6.2 Bayer AG Business Overview and Its Total Revenue
13.6.3 Bayer AG Personalized Medicine Introduction
13.6.4 Bayer AG Revenue in Personalized Medicine Business (2015-2020)
13.6.5 Bayer AG Recent Development
13.7 Celgene Corporation
13.7.1 Celgene Corporation Company Details
13.7.2 Celgene Corporation Business Overview and Its Total Revenue
13.7.3 Celgene Corporation Personalized Medicine Introduction
13.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2015-2020)
13.7.5 Celgene Corporation Recent Development
13.8 Glaxosmithkline Plc
13.8.1 Glaxosmithkline Plc Company Details
13.8.2 Glaxosmithkline Plc Business Overview and Its Total Revenue
13.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
13.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2015-2020)
13.8.5 Glaxosmithkline Plc Recent Development
13.9 Illumina
13.9.1 Illumina Company Details
13.9.2 Illumina Business Overview and Its Total Revenue
13.9.3 Illumina Personalized Medicine Introduction
13.9.4 Illumina Revenue in Personalized Medicine Business (2015-2020)
13.9.5 Illumina Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
13.10.3 Johnson & Johnson Personalized Medicine Introduction
13.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Laboratory Corporation
10.11.1 Laboratory Corporation Company Details
10.11.2 Laboratory Corporation Business Overview and Its Total Revenue
10.11.3 Laboratory Corporation Personalized Medicine Introduction
10.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2015-2020)
10.11.5 Laboratory Corporation Recent Development
13.12 Merck
10.12.1 Merck Company Details
10.12.2 Merck Business Overview and Its Total Revenue
10.12.3 Merck Personalized Medicine Introduction
10.12.4 Merck Revenue in Personalized Medicine Business (2015-2020)
10.12.5 Merck Recent Development
13.13 Novartis AG
10.13.1 Novartis AG Company Details
10.13.2 Novartis AG Business Overview and Its Total Revenue
10.13.3 Novartis AG Personalized Medicine Introduction
10.13.4 Novartis AG Revenue in Personalized Medicine Business (2015-2020)
10.13.5 Novartis AG Recent Development
13.14 Roche Holding AG
10.14.1 Roche Holding AG Company Details
10.14.2 Roche Holding AG Business Overview and Its Total Revenue
10.14.3 Roche Holding AG Personalized Medicine Introduction
10.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2015-2020)
10.14.5 Roche Holding AG Recent Development
13.15 Siemens AG
10.15.1 Siemens AG Company Details
10.15.2 Siemens AG Business Overview and Its Total Revenue
10.15.3 Siemens AG Personalized Medicine Introduction
10.15.4 Siemens AG Revenue in Personalized Medicine Business (2015-2020)
10.15.5 Siemens AG Recent Development
13.16 Takeda Pharmaceutical Company Limited
10.16.1 Takeda Pharmaceutical Company Limited Company Details
10.16.2 Takeda Pharmaceutical Company Limited Business Overview and Its Total Revenue
10.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
10.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2015-2020)
10.16.5 Takeda Pharmaceutical Company Limited Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Personalized Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Personalized Medicine Revenue
Table 3. Ranking of Global Top Personalized Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Personalized Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Personalized Medicine Diagnostics
Table 6. Key Players of Personalized Medical Care
Table 7. Key Players of Personalized Medicine Therapeutics
Table 8. Key Players of Personalized Nutrition and Wellness
Table 9. COVID-19 Impact Global Market: (Four Personalized Medicine Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Personalized Medicine Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Personalized Medicine Players to Combat Covid-19 Impact
Table 14. Global Personalized Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Personalized Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Personalized Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Personalized Medicine Market Share by Regions (2015-2020)
Table 18. Global Personalized Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Personalized Medicine Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Personalized Medicine Market Growth Strategy
Table 24. Main Points Interviewed from Key Personalized Medicine Players
Table 25. Global Personalized Medicine Revenue by Players (2015-2020) (Million US$)
Table 26. Global Personalized Medicine Market Share by Players (2015-2020)
Table 27. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2019)
Table 28. Global Personalized Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Personalized Medicine Product Solution and Service
Table 31. Date of Enter into Personalized Medicine Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 34. Global Personalized Medicine Market Size Share by Type (2015-2020)
Table 35. Global Personalized Medicine Revenue Market Share by Type (2021-2026)
Table 36. Global Personalized Medicine Market Size Share by Application (2015-2020)
Table 37. Global Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 38. Global Personalized Medicine Market Size Share by Application (2021-2026)
Table 39. North America Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Personalized Medicine Market Share (2019-2020)
Table 41. North America Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 42. North America Personalized Medicine Market Share by Type (2015-2020)
Table 43. North America Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 44. North America Personalized Medicine Market Share by Application (2015-2020)
Table 45. Europe Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Personalized Medicine Market Share (2019-2020)
Table 47. Europe Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Personalized Medicine Market Share by Type (2015-2020)
Table 49. Europe Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Personalized Medicine Market Share by Application (2015-2020)
Table 51. China Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 52. China Key Players Personalized Medicine Market Share (2019-2020)
Table 53. China Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 54. China Personalized Medicine Market Share by Type (2015-2020)
Table 55. China Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 56. China Personalized Medicine Market Share by Application (2015-2020)
Table 57. Japan Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Personalized Medicine Market Share (2019-2020)
Table 59. Japan Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Personalized Medicine Market Share by Type (2015-2020)
Table 61. Japan Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Personalized Medicine Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Personalized Medicine Market Share (2019-2020)
Table 65. Southeast Asia Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Personalized Medicine Market Share by Type (2015-2020)
Table 67. Southeast Asia Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Personalized Medicine Market Share by Application (2015-2020)
Table 69. India Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 70. India Key Players Personalized Medicine Market Share (2019-2020)
Table 71. India Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 72. India Personalized Medicine Market Share by Type (2015-2020)
Table 73. India Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 74. India Personalized Medicine Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Personalized Medicine Market Share (2019-2020)
Table 77. Central & South America Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Personalized Medicine Market Share by Type (2015-2020)
Table 79. Central & South America Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Personalized Medicine Market Share by Application (2015-2020)
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 85. Abbott Laboratories Recent Development
Table 86. Agilent Technologies Company Details
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies Product
Table 89. Agilent Technologies Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 90. Agilent Technologies Recent Development
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Product
Table 94. Amgen Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 95. Amgen Recent Development
Table 96. Astellas Pharma Company Details
Table 97. Astellas Pharma Business Overview
Table 98. Astellas Pharma Product
Table 99. Astellas Pharma Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 100. Astellas Pharma Recent Development
Table 101. Astrazeneca Company Details
Table 102. Astrazeneca Business Overview
Table 103. Astrazeneca Product
Table 104. Astrazeneca Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 105. Astrazeneca Recent Development
Table 106. Bayer AG Company Details
Table 107. Bayer AG Business Overview
Table 108. Bayer AG Product
Table 109. Bayer AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 110. Bayer AG Recent Development
Table 111. Celgene Corporation Company Details
Table 112. Celgene Corporation Business Overview
Table 113. Celgene Corporation Product
Table 114. Celgene Corporation Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 115. Celgene Corporation Recent Development
Table 116. Glaxosmithkline Plc Business Overview
Table 117. Glaxosmithkline Plc Product
Table 118. Glaxosmithkline Plc Company Details
Table 119. Glaxosmithkline Plc Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 120. Glaxosmithkline Plc Recent Development
Table 121. Illumina Company Details
Table 122. Illumina Business Overview
Table 123. Illumina Product
Table 124. Illumina Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 125. Illumina Recent Development
Table 126. Johnson & Johnson Company Details
Table 127. Johnson & Johnson Business Overview
Table 128. Johnson & Johnson Product
Table 129. Johnson & Johnson Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 130. Johnson & Johnson Recent Development
Table 131. Laboratory Corporation Company Details
Table 132. Laboratory Corporation Business Overview
Table 133. Laboratory Corporation Product
Table 134. Laboratory Corporation Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 135. Laboratory Corporation Recent Development
Table 136. Merck Company Details
Table 137. Merck Business Overview
Table 138. Merck Product
Table 139. Merck Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 140. Merck Recent Development
Table 141. Novartis AG Company Details
Table 142. Novartis AG Business Overview
Table 143. Novartis AG Product
Table 144. Novartis AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 145. Novartis AG Recent Development
Table 146. Roche Holding AG Company Details
Table 147. Roche Holding AG Business Overview
Table 148. Roche Holding AG Product
Table 149. Roche Holding AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 150. Roche Holding AG Recent Development
Table 151. Siemens AG Company Details
Table 152. Siemens AG Business Overview
Table 153. Siemens AG Product
Table 154. Siemens AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 155. Siemens AG Recent Development
Table 156. Takeda Pharmaceutical Company Limited Company Details
Table 157. Takeda Pharmaceutical Company Limited Business Overview
Table 158. Takeda Pharmaceutical Company Limited Product
Table 159. Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 160. Takeda Pharmaceutical Company Limited Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 1. Personalized Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Personalized Medicine Revenue
Table 3. Ranking of Global Top Personalized Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Personalized Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Personalized Medicine Diagnostics
Table 6. Key Players of Personalized Medical Care
Table 7. Key Players of Personalized Medicine Therapeutics
Table 8. Key Players of Personalized Nutrition and Wellness
Table 9. COVID-19 Impact Global Market: (Four Personalized Medicine Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Personalized Medicine Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Personalized Medicine Players to Combat Covid-19 Impact
Table 14. Global Personalized Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Personalized Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Personalized Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Personalized Medicine Market Share by Regions (2015-2020)
Table 18. Global Personalized Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Personalized Medicine Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Personalized Medicine Market Growth Strategy
Table 24. Main Points Interviewed from Key Personalized Medicine Players
Table 25. Global Personalized Medicine Revenue by Players (2015-2020) (Million US$)
Table 26. Global Personalized Medicine Market Share by Players (2015-2020)
Table 27. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2019)
Table 28. Global Personalized Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Personalized Medicine Product Solution and Service
Table 31. Date of Enter into Personalized Medicine Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 34. Global Personalized Medicine Market Size Share by Type (2015-2020)
Table 35. Global Personalized Medicine Revenue Market Share by Type (2021-2026)
Table 36. Global Personalized Medicine Market Size Share by Application (2015-2020)
Table 37. Global Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 38. Global Personalized Medicine Market Size Share by Application (2021-2026)
Table 39. North America Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Personalized Medicine Market Share (2019-2020)
Table 41. North America Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 42. North America Personalized Medicine Market Share by Type (2015-2020)
Table 43. North America Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 44. North America Personalized Medicine Market Share by Application (2015-2020)
Table 45. Europe Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Personalized Medicine Market Share (2019-2020)
Table 47. Europe Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Personalized Medicine Market Share by Type (2015-2020)
Table 49. Europe Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Personalized Medicine Market Share by Application (2015-2020)
Table 51. China Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 52. China Key Players Personalized Medicine Market Share (2019-2020)
Table 53. China Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 54. China Personalized Medicine Market Share by Type (2015-2020)
Table 55. China Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 56. China Personalized Medicine Market Share by Application (2015-2020)
Table 57. Japan Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Personalized Medicine Market Share (2019-2020)
Table 59. Japan Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Personalized Medicine Market Share by Type (2015-2020)
Table 61. Japan Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Personalized Medicine Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Personalized Medicine Market Share (2019-2020)
Table 65. Southeast Asia Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Personalized Medicine Market Share by Type (2015-2020)
Table 67. Southeast Asia Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Personalized Medicine Market Share by Application (2015-2020)
Table 69. India Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 70. India Key Players Personalized Medicine Market Share (2019-2020)
Table 71. India Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 72. India Personalized Medicine Market Share by Type (2015-2020)
Table 73. India Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 74. India Personalized Medicine Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Personalized Medicine Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Personalized Medicine Market Share (2019-2020)
Table 77. Central & South America Personalized Medicine Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Personalized Medicine Market Share by Type (2015-2020)
Table 79. Central & South America Personalized Medicine Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Personalized Medicine Market Share by Application (2015-2020)
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 85. Abbott Laboratories Recent Development
Table 86. Agilent Technologies Company Details
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies Product
Table 89. Agilent Technologies Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 90. Agilent Technologies Recent Development
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Product
Table 94. Amgen Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 95. Amgen Recent Development
Table 96. Astellas Pharma Company Details
Table 97. Astellas Pharma Business Overview
Table 98. Astellas Pharma Product
Table 99. Astellas Pharma Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 100. Astellas Pharma Recent Development
Table 101. Astrazeneca Company Details
Table 102. Astrazeneca Business Overview
Table 103. Astrazeneca Product
Table 104. Astrazeneca Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 105. Astrazeneca Recent Development
Table 106. Bayer AG Company Details
Table 107. Bayer AG Business Overview
Table 108. Bayer AG Product
Table 109. Bayer AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 110. Bayer AG Recent Development
Table 111. Celgene Corporation Company Details
Table 112. Celgene Corporation Business Overview
Table 113. Celgene Corporation Product
Table 114. Celgene Corporation Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 115. Celgene Corporation Recent Development
Table 116. Glaxosmithkline Plc Business Overview
Table 117. Glaxosmithkline Plc Product
Table 118. Glaxosmithkline Plc Company Details
Table 119. Glaxosmithkline Plc Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 120. Glaxosmithkline Plc Recent Development
Table 121. Illumina Company Details
Table 122. Illumina Business Overview
Table 123. Illumina Product
Table 124. Illumina Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 125. Illumina Recent Development
Table 126. Johnson & Johnson Company Details
Table 127. Johnson & Johnson Business Overview
Table 128. Johnson & Johnson Product
Table 129. Johnson & Johnson Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 130. Johnson & Johnson Recent Development
Table 131. Laboratory Corporation Company Details
Table 132. Laboratory Corporation Business Overview
Table 133. Laboratory Corporation Product
Table 134. Laboratory Corporation Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 135. Laboratory Corporation Recent Development
Table 136. Merck Company Details
Table 137. Merck Business Overview
Table 138. Merck Product
Table 139. Merck Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 140. Merck Recent Development
Table 141. Novartis AG Company Details
Table 142. Novartis AG Business Overview
Table 143. Novartis AG Product
Table 144. Novartis AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 145. Novartis AG Recent Development
Table 146. Roche Holding AG Company Details
Table 147. Roche Holding AG Business Overview
Table 148. Roche Holding AG Product
Table 149. Roche Holding AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 150. Roche Holding AG Recent Development
Table 151. Siemens AG Company Details
Table 152. Siemens AG Business Overview
Table 153. Siemens AG Product
Table 154. Siemens AG Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 155. Siemens AG Recent Development
Table 156. Takeda Pharmaceutical Company Limited Company Details
Table 157. Takeda Pharmaceutical Company Limited Business Overview
Table 158. Takeda Pharmaceutical Company Limited Product
Table 159. Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2015-2020) (Million US$)
Table 160. Takeda Pharmaceutical Company Limited Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Personalized Medicine Market Share by Type: 2020 VS 2026
Figure 2. Personalized Medicine Diagnostics Features
Figure 3. Personalized Medical Care Features
Figure 4. Personalized Medicine Therapeutics Features
Figure 5. Personalized Nutrition and Wellness Features
Figure 6. Global Personalized Medicine Market Share by Application: 2020 VS 2026
Figure 7. Oncology Case Studies
Figure 8. Central Nervous System (CNS) Case Studies
Figure 9. Immunology Case Studies
Figure 10. Respiratory Case Studies
Figure 11. Other Applications Case Studies
Figure 12. Personalized Medicine Report Years Considered
Figure 13. Global Personalized Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Personalized Medicine Market Share by Regions: 2020 VS 2026
Figure 15. Global Personalized Medicine Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Personalized Medicine Market Share by Players in 2019
Figure 18. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Personalized Medicine Revenue in 2019
Figure 20. North America Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Abbott Laboratories Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 29. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Agilent Technologies Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 31. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Amgen Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 33. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Astellas Pharma Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 35. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Astrazeneca Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 37. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 39. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Celgene Corporation Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 41. Glaxosmithkline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Glaxosmithkline Plc Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 43. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Illumina Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 45. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Johnson & Johnson Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 47. Laboratory Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Laboratory Corporation Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 51. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 53. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Roche Holding AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 55. Siemens AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Siemens AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 57. Takeda Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Figure 1. Global Personalized Medicine Market Share by Type: 2020 VS 2026
Figure 2. Personalized Medicine Diagnostics Features
Figure 3. Personalized Medical Care Features
Figure 4. Personalized Medicine Therapeutics Features
Figure 5. Personalized Nutrition and Wellness Features
Figure 6. Global Personalized Medicine Market Share by Application: 2020 VS 2026
Figure 7. Oncology Case Studies
Figure 8. Central Nervous System (CNS) Case Studies
Figure 9. Immunology Case Studies
Figure 10. Respiratory Case Studies
Figure 11. Other Applications Case Studies
Figure 12. Personalized Medicine Report Years Considered
Figure 13. Global Personalized Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Personalized Medicine Market Share by Regions: 2020 VS 2026
Figure 15. Global Personalized Medicine Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Personalized Medicine Market Share by Players in 2019
Figure 18. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Medicine as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Personalized Medicine Revenue in 2019
Figure 20. North America Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Personalized Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Abbott Laboratories Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 29. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Agilent Technologies Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 31. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Amgen Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 33. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Astellas Pharma Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 35. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Astrazeneca Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 37. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 39. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Celgene Corporation Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 41. Glaxosmithkline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Glaxosmithkline Plc Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 43. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Illumina Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 45. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Johnson & Johnson Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 47. Laboratory Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Laboratory Corporation Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 51. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 53. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Roche Holding AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 55. Siemens AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Siemens AG Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 57. Takeda Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Personalized Medicine Business (2015-2020)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
